Table 3.

Pathway enrichment in the group of patients at high risk of hypoxia in the Gene Expression Omnibus database.

NAME	SIZE	ES	NES	NOM p-val	FDR q-val	FWER p-val
HEDGEHOG_SIGNALING	35	0.47144	1.277345	0.14038461	1	0.749
WNT_BETA_CATENIN_SIGNALING	41	0.430082	1.2600657	0.15187377	0.96750426	0.763
EPITHELIAL_MESENCHYMAL_TRANSITION	195	0.5649699	1.176124	0.33539096	0.9005055	0.86
ANGIOGENESIS	35	0.46240142	1.0144869	0.45738044	1	0.956
MYOGENESIS	196	0.3335677	0.9412718	0.5278351	1	0.983
UV_RESPONSE_DN	135	0.3387805	0.9249301	0.5495868	0.99989307	0.985
TGF_BETA_SIGNALING	52	0.33623004	0.9151217	0.5373737	0.88053614	0.985
KRAS_SIGNALING_DN	190	0.263007	0.8919948	0.642562	0.81584287	0.987
APICAL_SURFACE	43	0.27583465	0.7981121	0.813278	0.91715556	0.996
KRAS_SIGNALING_UP	192	0.30013293	0.7668628	0.806	0.8810992	0.997
ANDROGEN_RESPONSE	93	0.22268894	0.7156268	0.86470586	0.8806738	0.998
COAGULATION	136	0.2703017	0.67810416	0.9207317	0.8534861	0.998